13075_2016_981_MOESM4_ESM.doc (49 kB)
Additional file 4: of A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study
journal contribution
posted on 2016-04-02, 05:00 authored by Dae Yoo, Artur Racewicz, Jan Brzezicki, Roman Yatsyshyn, Edgardo Arteaga, Asta Baranauskaite, Carlos Abud-Mendoza, Sandra Navarra, Vladimir Kadinov, Irmgadt Sariego, Seung Hong, Sung Lee, Won ParkOverview of treatment-related serious adverse events occurring by severity (n [%]). (DOC 49 kb)